77 related articles for article (PubMed ID: 7482409)
1. IL-6 upregulates protein S expression in the HepG-2 hepatoma cells.
Hooper WC; Phillips DJ; Ribeiro M; Benson J; Evatt BL
Thromb Haemost; 1995 May; 73(5):819-24. PubMed ID: 7482409
[TBL] [Abstract][Full Text] [Related]
2. The production of heparin cofactor II is not regulated by inflammatory cytokines in human hepatoma cells: comparison with plasminogen activator inhibitor type-1.
Koike C; Hayakawa Y; Niiya K; Sakuragawa N; Sasaki H
Thromb Haemost; 1996 Feb; 75(2):298-302. PubMed ID: 8815580
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.
Hooper WC; Phillips DJ; Evatt BL
Thromb Haemost; 1997 May; 77(5):1014-9. PubMed ID: 9184420
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
5. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
6. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells.
Baumann H; Richards C; Gauldie J
J Immunol; 1987 Dec; 139(12):4122-8. PubMed ID: 2447159
[TBL] [Abstract][Full Text] [Related]
7. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide.
Fouqueray B; Boutard V; Philippe C; Kornreich A; Marchant A; Perez J; Goldman M; Baud L
Am J Pathol; 1995 Jul; 147(1):176-82. PubMed ID: 7604878
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 is a negative regulator of the acute phase alpha 1-inhibitor III gene.
Abraham LJ; Bradshaw AD; Fletcher RG; Fey GH
Mol Biol Med; 1990 Jun; 7(3):261-71. PubMed ID: 1699110
[TBL] [Abstract][Full Text] [Related]
9. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
10. Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region.
Kalina U; Koyama N; Hosoda T; Nuernberger H; Sato K; Hoelzer D; Herweck F; Manigold T; Singer MV; Rossol S; Böcker U
Eur J Immunol; 2002 Sep; 32(9):2635-43. PubMed ID: 12207348
[TBL] [Abstract][Full Text] [Related]
11. In vitro modulation of cisplatin resistance by cytokines.
Poppenborg H; Knüpfer MM; Galla HJ; Wolff JE
Cytokine; 1999 Sep; 11(9):689-95. PubMed ID: 10479405
[TBL] [Abstract][Full Text] [Related]
12. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
Geisterfer M; Richards CD; Gauldie J
Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
[TBL] [Abstract][Full Text] [Related]
13. Divergent transforming growth factor-beta effects on IL-6 regulation of acute phase plasma proteins in rat hepatoma cells.
Campos SP; Wang Y; Koj A; Baumann H
J Immunol; 1993 Dec; 151(12):7128-37. PubMed ID: 7505021
[TBL] [Abstract][Full Text] [Related]
14. IL-6-induced changes in synthesis of alpha 1-acid glycoprotein in human hepatoma Hep3B cells are distinctively regulated by monoclonal antibodies directed against different epitopes of IL-6 receptor (gp80).
Daveau M; Liautard J; Gaillard JP; Hiron M; Brochier J; Lebreton JP
Eur Cytokine Netw; 1994; 5(6):601-8. PubMed ID: 7537107
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
[TBL] [Abstract][Full Text] [Related]
16. Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells.
Giannì M; Norio P; Terao M; Falanga A; Marchetti M; Rambaldi A; Garattini E
Eur Cytokine Netw; 1995; 6(3):157-65. PubMed ID: 8589272
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells.
Hakkola J; Hu Y; Ingelman-Sundberg M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1048-54. PubMed ID: 12604681
[TBL] [Abstract][Full Text] [Related]
18. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
Wang M; Fudge K; Rhim JS; Stearns ME
Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta (TGF-beta) inhibits expression of fibrinogen and factor VII in a hepatoma cell line.
Hassan JH; Chelucci C; Peschle C; Sorrentino V
Thromb Haemost; 1992 Apr; 67(4):478-83. PubMed ID: 1321511
[TBL] [Abstract][Full Text] [Related]
20. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.
Lotem J; Sachs L
Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
